XRH43GB
Insertion Cervicothoracic Vertebral Joint to New Technology Group 11 with Molybdenum Rhenium Alloy Spinal Stabilization Device, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | R Joints |
| Operation | H Insertion |
| Body Part | 4 Cervicothoracic Vertebral Joint |
| Approach | 3 Percutaneous |
| Device | G Molybdenum Rhenium Alloy Spinal Stabilization Device |
| Qualifier | B New Technology Group 11 |
Operation Definition
Putting in a nonbiological appliance that monitors, assists, performs, or prevents a physiological function but does not physically take the place of a body part
Procedure Overview
This family describes placing a nonbiological device into a joint to monitor, assist, or otherwise support its physiological function without permanently immobilizing it or replacing joint components. Rather than fusing or replacing the joint, the device is left in place to perform an ongoing role, such as tracking load or pressure, delivering therapeutic stimulation, or assisting movement, and it is classified under New Technology because of its novel design or function.
Candidates for these procedures are often patients with chronic joint instability, early degenerative changes, or a need for objective data on joint mechanics that standard imaging cannot provide, or those receiving an implanted device intended to support joint function over time rather than replace worn-out surfaces outright. Because the joint itself is not resected or fused, patients generally retain a greater range of native motion than they would after replacement or fusion surgery.
Anatomy & Axis Detail
Cervicothoracic Vertebral Joint
The cervicothoracic vertebral joint refers to the transitional articulation at the junction between the lowest cervical and uppermost thoracic vertebrae, a region subject to distinct biomechanical stress as spinal curvature shifts from lordotic to kyphotic. This transition zone can be affected by degenerative change, deformity, or instability that does not fit cleanly into either purely cervical or purely thoracic categories, making device insertion here anatomically and surgically distinct. Because the vertebral artery, brachial plexus roots, and upper mediastinal structures lie near this junction, approach and device placement require careful documentation. The new technology code specifically identifies insertion of a device at this cervicothoracic level using a technique or implant that represents an advance beyond existing cervical or thoracic insertion and fusion codes.
Approach: Percutaneous
In New Technology, Percutaneous describes entry into the body via needle or instrument puncture through the skin or a mucous membrane, without a surgical incision, mirroring the same concept in Medical and Surgical. It is distinguished from Open access, which requires a full incision, and from Percutaneous Endoscopic, which adds visualization through the puncture site.
Device / Substance / Technology: Molybdenum Rhenium Alloy Spinal Stabilization Device
This spinal stabilization device is fabricated from a molybdenum-rhenium alloy, a material choice that differs from the titanium or cobalt-chromium alloys used in conventional instrumentation, generally selected for a combination of strength, fatigue resistance, and imaging characteristics. It is reported separately from standard titanium constructs because the alloy composition represents a distinct New Technology material rather than a variation in device shape or fixation mechanism.
Qualifier: New Technology Group 11
This qualifier designates Group 11, the most recent cohort at the time of its introduction, grouping technologies newly approved for New Technology section reporting in that fiscal year. Like every group value in this axis, it functions as an administrative marker rather than a description of the clinical intervention, which is captured elsewhere in the code. Its main point of confusion is with Group 10, the immediately preceding annual release.
Coding & Documentation
Coders should confirm the operative note describes insertion of a distinct appliance into or around the joint, with the device's name or type matching an approved New Technology entry, and that no joint component was removed or replaced in the process. Clear documentation of what the device does - monitoring, assisting, or stimulating - helps confirm Insertion is the correct root operation rather than Replacement or Supplement.
A common mistake is coding this as a joint replacement procedure when the joint surfaces were left untouched and only a supportive device was added. Coders should also watch for cases where an inserted device is later removed or revised, which require different root operations than the original Insertion code.